These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 12538484

  • 1. Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.
    Alas S, Bonavida B.
    Clin Cancer Res; 2003 Jan; 9(1):316-26. PubMed ID: 12538484
    [Abstract] [Full Text] [Related]

  • 2. Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs.
    Alas S, Bonavida B.
    Cancer Res; 2001 Jul 01; 61(13):5137-44. PubMed ID: 11431352
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.
    Alas S, Emmanouilides C, Bonavida B.
    Clin Cancer Res; 2001 Mar 01; 7(3):709-23. PubMed ID: 11297268
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of JAK kinase activity enhances Fas-mediated apoptosis but reduces cytotoxic activity of topoisomerase II inhibitors in U266 myeloma cells.
    Oshiro MM, Landowski TH, Catlett-Falcone R, Hazlehurst LA, Huang M, Jove R, Dalton WS.
    Clin Cancer Res; 2001 Dec 01; 7(12):4262-71. PubMed ID: 11751528
    [Abstract] [Full Text] [Related]

  • 5. Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistance.
    Vega MI, Huerta-Yepaz S, Garban H, Jazirehi A, Emmanouilides C, Bonavida B.
    Oncogene; 2004 Apr 29; 23(20):3530-40. PubMed ID: 15077178
    [Abstract] [Full Text] [Related]

  • 6. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis.
    Jazirehi AR, Bonavida B.
    Mol Cancer Ther; 2004 Jan 29; 3(1):71-84. PubMed ID: 14749477
    [Abstract] [Full Text] [Related]

  • 7. JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells.
    De Vos J, Jourdan M, Tarte K, Jasmin C, Klein B.
    Br J Haematol; 2000 Jun 29; 109(4):823-8. PubMed ID: 10929036
    [Abstract] [Full Text] [Related]

  • 8. Modulation of Janus kinase 2 by cisplatin in cancer cells.
    Song H, Sondak VK, Barber DL, Reid TJ, Lin J.
    Int J Oncol; 2004 Apr 29; 24(4):1017-26. PubMed ID: 15010843
    [Abstract] [Full Text] [Related]

  • 9. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.
    Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernández-Luna JL, Nuñez G, Dalton WS, Jove R.
    Immunity; 1999 Jan 29; 10(1):105-15. PubMed ID: 10023775
    [Abstract] [Full Text] [Related]

  • 10. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells.
    Real PJ, Sierra A, De Juan A, Segovia JC, Lopez-Vega JM, Fernandez-Luna JL.
    Oncogene; 2002 Oct 31; 21(50):7611-8. PubMed ID: 12400004
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells.
    Burke WM, Jin X, Lin HJ, Huang M, Liu R, Reynolds RK, Lin J.
    Oncogene; 2001 Nov 29; 20(55):7925-34. PubMed ID: 11753675
    [Abstract] [Full Text] [Related]

  • 12. IL-6 inhibits apoptosis of human myeloma cell line XG-7 through activation of JAK/STAT pathway and up-regulation of Mcl-1.
    Song L, Li Y, Sun YX, Yu M, Shen BF.
    Ai Zheng; 2002 Feb 29; 21(2):113-6. PubMed ID: 12479056
    [Abstract] [Full Text] [Related]

  • 13. Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines.
    Barton BE, Karras JG, Murphy TF, Barton A, Huang HF.
    Mol Cancer Ther; 2004 Jan 29; 3(1):11-20. PubMed ID: 14749471
    [Abstract] [Full Text] [Related]

  • 14. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
    Spiekermann K, Biethahn S, Wilde S, Hiddemann W, Alves F.
    Eur J Haematol; 2001 Aug 29; 67(2):63-71. PubMed ID: 11722592
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of JAK1/STAT3 signaling mediates compound K-induced apoptosis in human multiple myeloma U266 cells.
    Park S, Lee HJ, Jeong SJ, Song HS, Kim M, Lee HJ, Lee EO, Kim DH, Ahn KS, Kim SH.
    Food Chem Toxicol; 2011 Jun 29; 49(6):1367-72. PubMed ID: 21420464
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells.
    Nielsen M, Kaestel CG, Eriksen KW, Woetmann A, Stokkedal T, Kaltoft K, Geisler C, Röpke C, Odum N.
    Leukemia; 1999 May 29; 13(5):735-8. PubMed ID: 10374878
    [Abstract] [Full Text] [Related]

  • 17. Role of STAT3 in ischemic preconditioning.
    Hattori R, Maulik N, Otani H, Zhu L, Cordis G, Engelman RM, Siddiqui MA, Das DK.
    J Mol Cell Cardiol; 2001 Nov 29; 33(11):1929-36. PubMed ID: 11708838
    [Abstract] [Full Text] [Related]

  • 18. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
    Sun J, Blaskovich MA, Jove R, Livingston SK, Coppola D, Sebti SM.
    Oncogene; 2005 May 05; 24(20):3236-45. PubMed ID: 15735720
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.